BGIM
GMED icon

Boussard & Gavaudan Investment Management’s Globus Medical GMED Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88,274
Closed -$4.44M – 85
2023
Q3 		$4.44M Buy
88,274
+7,117
+9% +$398K 0.52% 46
2023
Q2 		$4.82M Hold
81,157
– – 0.46% 55
2023
Q1 		$4.51M Buy
+81,157
New +$5.2M 0.42% 55

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boussard & Gavaudan Investment Management's GMED Position: Q4 2023 in Review

Boussard & Gavaudan Investment Management sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 88,274 shares — an estimated $4.44M sold.

Boussard & Gavaudan Investment Management first reported a position in GMED in Q1 2023 and held it in 3 quarters. The position peaked at $4.82M in Q2 2023. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Boussard & Gavaudan Investment Management reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 88,274 Globus Medical shares in Q4 2023, an estimated $4.44M.
  • Boussard & Gavaudan Investment Management first reported a position in Globus Medical in Q1 2023 and held it in 3 quarters.
  • Boussard & Gavaudan Investment Management's Globus Medical position peaked at $4.82M in Q2 2023.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.